发明名称 LYMPHOCYTIC ACTIVATION INHIBITOR AND REMEDIAL AGENT FOR AUTOIMMUNE DISEASE
摘要 A lymphocytic activation inhibitor and a remedial agent for autoimmune diseases which each comprises as an active ingredient a sulfonamide derivative or sulfonic ester derivative represented by the general formula I: I [wherein ring A means an optionally substituted, mono- or bicyclic aromatic ring ring B means an optionally substituted, 6-membered, cyclic unsaturated hydrocarbon or an unsaturated 6-membered heterocycle containing one nitrogen atom ring C means an optionally substituted 5-membered heterocycle containing one or two nitrogen atoms W means a single bond or -CH=CH- X means -NR1- or oxygen Y means carbon or nitrogen Z means -NR2- or nitrogen and R1 and R2 are the same or different and each means hydrogen or lower alkyl], a pharmacologically acceptable salt thereof, or a hydrate of any of these.
申请公布号 WO03022271(A1) 申请公布日期 2003.03.20
申请号 WO2002JP09030 申请日期 2002.09.05
申请人 EISAI C0. LTD.;HANADA, TAKAHISA;YAMAUCHI, TOSHIHIKO;CHIBA, KENICHI;OWA, TAKASHI;HIDA, TAKAYUKI;MIYAMOTO, NORIMASA 发明人 HANADA, TAKAHISA;YAMAUCHI, TOSHIHIKO;CHIBA, KENICHI;OWA, TAKASHI;HIDA, TAKAYUKI;MIYAMOTO, NORIMASA
分类号 A61K31/404;A61K31/416;A61K31/4178;A61K31/427;A61K31/437;A61K31/4439;A61K45/06;A61P1/00;A61P1/02;A61P3/10;A61P5/50;A61P19/02;A61P19/04;A61P25/00;A61P27/02;A61P29/00;A61P37/00;A61P37/02;(IPC1-7):A61K31/404;A61K31/417;A61K31/443;A61K45/00;C07D209/30;C07D209/34;C07D209/42;C07D231/56;C07D401/12;C07D403/12;C07D405/12;C07D409/14;C07D417/12;C07D471/04 主分类号 A61K31/404
代理机构 代理人
主权项
地址